-- Days : -- HRS : -- MIN : -- SEC
Register Now →
|Videos|November 28, 2019

Top 5 AJMC® Articles of November 2019

Here are the top 5 articles for the month of November.

Hi, this is Laura Joszt for The American Journal of Managed Care®. Here are the top 5 articles for the month of November.

Number 5: Data presented at the 2019 American Heart Association Scientific Sessions may have answered how a purified fish oil pill reduces cardiovascular events. The research suggests the pill helps slow the advance of various coronary plaques.

Number 4: At the American Society of Nephrology's Kidney Week 2019 investigators presented data about 3 phase 3 trials of roxadustat. The trials showed promising results about the first-in-class oral drug to treat chronic kidney disease in patients with anemia.

Number 3: First Stop Health’s inaugural 2019 Health Benefits Cost Containment Report found that reigning in benefits spending is a top priority for employers, but many lack the data necessary to make effective changes.

Number 2: Results from ISCHEMIA, presented at the American Heart Association Scientific Sessions, showed invasive procedures like stents are often no better than medical therapy and lifestyle changes at preventing a heart attack in patients with stable heart disease.

Number 1: CMS has launched the process to craft what will come after the Oncology Care Model, the 5-year alternative payment model that ends in 2021. The successor, Oncology Care First, would include a prospective, monthly population payment; accountability for total costs of care incurred over a 6-month episode; changes to make attribution more predictable, and electronic patient-reported outcomes.

To read all of these articles and more, visit ajmc.com.


Related to this article

Anthony Stein, MD | Image: City of Hope
At an AJMC® Stakeholder Interchange in Los Angeles, leukemia specialists described a region where hospital formularies push menin inhibitor starts into the clinic, emergency department (ED) physicians may not recognize differentiation syndrome, and capitated insurance contracts steer some patients with acute myeloid leukemia away from academic centers.